Skip to content

Dr. Samira Hijjit

Active
Private limited companyfounded 2022active for 4 yearsKruisstraat 20, 3590 Diepenbeek, BelgiumKBO/BCE: BE 0793.146.828

From the official registers: KBO 3 annual accounts at the National Bank publications in the Belgian Official Gazette

Summary

Dr. Samira Hijjit has been active since 2022 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €702,814 and a net result of €265,530. Equity has been growing by about 51% per year since 2023. Its solvency ranks better than 82% of 20,678 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).

Overview

Official details

KBO
Status
Active since 28-10-2022 Normal situation
Activity
Specialist medical practice NACE 86220
Establishment unit
2.338.078.991 3590 Diepenbeek, since 01-11-2022
Financial year end
31 December
Peppol
Reachable since 24-11-2023

Board and ownership

Board

Financial position

97 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
< 0.1%
Annual accounts 2025
Gross margin
€339,306
▲ 46.7%
Turnover
≈ €520,000
estimated
Profit
€265,530
▲ 43.9%
Equity
€702,814
▲ 60.7%
Total assets
€791,396
▲ 58.3%
Staff
≈ 0 FTE
estimated
Filed on 23-06-2026, 38 days before the deadlineat the National Bank
Score breakdownraises risk1 change of registered office in 24 monthslowers riskSector: Human health activities (NACE 86)Liquidity: current ratio 8.88, cash €183,595Figures for financial year 2025 (filed on 23-06-2026)Show the evidence

Checked score

Score 2025
97 / 100
Excellent
Probability in this band: under 0.55%
Financially stronger than 76% of micro companies in human health (NACE 86)
Financial strength · tick: 2024
Strong
Solvency 100=
equity 88.8% of total assets
Liquidity 78+18
short-term debt 11.0% · cash 23.2%
Profitability 100=
return on assets 33.6%
Bankruptcy probability within 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,155 companies, NACE 86, micro)
Last 24 months 11-2024: < 0.1%lowest value 12-2024: < 0.1%● unchanged vs 11-2024lowest value 01-2025: < 0.1%● unchanged vs 12-2024 02-2025: < 0.1%● unchanged vs 01-2025 03-2025: < 0.1%● unchanged vs 02-2025 04-2025: < 0.1%● unchanged vs 03-2025 05-2025: 0.1%▲ +0.1 percentage points vs 04-2025 06-2025: 0.1%● unchanged vs 05-2025 07-2025: 0.1%● unchanged vs 06-2025 08-2025: 0.2%▲ +0.1 percentage points vs 07-2025 09-2025: 0.2%● unchanged vs 08-2025 10-2025: 0.2%● unchanged vs 09-2025 11-2025: 0.2%● unchanged vs 10-2025 12-2025: 0.2%● unchanged vs 11-2025 01-2026: 0.2%● unchanged vs 12-2025 02-2026: 0.2%● unchanged vs 01-2026 03-2026: 0.2%● unchanged vs 02-2026 04-2026: 0.2%● unchanged vs 03-2026 05-2026: 0.2%● unchanged vs 04-2026 06-2026: 0.2%● unchanged vs 05-2026 07-2026: 0.2%● unchanged vs 06-2026 08-2026: 0.3%▲ +0.1 percentage points vs 07-2026 09-2026: 0.4%▲ +0.1 percentage points vs 08-2026highest value 10-2026: < 0.1%▼ -0.4 percentage points vs 09-2026
Credit of up to €65,000 on 30-day terms is acceptable
Liquidity is ample, with a current ratio of 8.88 (8.36 in 2024), above the usual 1.5. Short-term debt is 11% and cash 23.2% of total assets. 11.2% of the assets are financed with debt and provisions.
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro). It does better than 82% of them on solvency, 60% on liquidity, 80% on profitability and 83% on growth.

The bankruptcy probability was computed on 31-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Five signals.
lowers riskraises riskneutral
lowers risk · Sector: Human health activities (NACE 86)
KBO
raises risk · 1 change of registered office in 24 months
Belgian Official Gazette
lowers risk · Liquidity: current ratio 8.88, cash €183,595
NBB · annual accounts
lowers risk · Figures for financial year 2025 (filed on 23-06-2026)
NBB · annual accounts
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 23-06-2026, 38 days ahead of the deadline.
NBB · 3 filings
Deviation from the deadline
2025
38 days early
2024
7 days early
2023
13 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 3 accounts on average 19 days before the deadline. In the sector (NACE 86), the median for financial year 2024 was 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 19 July (3 of the last 3 accounts filed within 30 days either side of that date).
Companies Code · seven months
Where today falls in the filing period
01-11-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
That holds for every publication since incorporation in 2022.
KBO publications

Key points

  • Positive: Higher net result than 93% of companies in human healthsector median €60,139 · 20,665 companies €265,530 View
  • Positive: Equity rose in 2025from €437,284 to €702,814 ▲ 60.7% View

Comparable companies

These companies have the same main activity as Dr. Samira Hijjit: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €756,000 and €853,000, founded between 2022 and 2023.

CompanyTotal assetsGross margin
Dr. Samira Hijjit Diepenbeek€791,396€339,306
Dokter Laura Vanhoof Genk€767,681€347,630
De Biestert Bilzen-Hoeselt€853,222€385,116
RX AURÈS Brussel€797,076€342,931
DOCTEUR SOPHIE HERENS BIOCLIN Liège€756,369€352,378
Charlottedf Schilde€795,642€342,119
Dokter Inge Muylle, pneumologie Anderlecht€820,926€330,707
Full comparison

Documents

Annual accounts at the NBB

Acts in the Belgian Official Gazette

All publications in the Belgian Official Gazette

Articles and registers

Key facts about Dr. Samira Hijjit

What is the company number of Dr. Samira Hijjit?
The company number of Dr. Samira Hijjit is 0793.146.828. The VAT number is the same number with BE in front: BE 0793.146.828.
Where is Dr. Samira Hijjit based?
The registered office is at Kruisstraat 20, 3590 Diepenbeek.Company details
What does Dr. Samira Hijjit do?
According to the KBO register, the main activity is specialist medical practice (NACE 86220).
What is the legal form of Dr. Samira Hijjit?
The legal form of Dr. Samira Hijjit is Private limited company (BV).
When was Dr. Samira Hijjit founded?
Dr. Samira Hijjit was founded on 28-10-2022.
Is Dr. Samira Hijjit still active?
Yes, Dr. Samira Hijjit is an active enterprise in the KBO register.
What is the turnover of Dr. Samira Hijjit?
The turnover in financial year 2025 is ≈ €520,000. This figure is estimated from the gross margin of €339,306 and 36 comparable companies (NACE 862). It probably lies between €470,000 and €660,000.Financials
Is Dr. Samira Hijjit profitable?
In financial year 2025, Dr. Samira Hijjit made a profit of €265,530.
Where can I find the annual accounts of Dr. Samira Hijjit?
Dr. Samira Hijjit filed 3 annual accounts with the National Bank of Belgium, the latest for financial year 2025.Annual accounts at the National Bank
When are the next annual accounts of Dr. Samira Hijjit due?
Dr. Samira Hijjit must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.